Quintero J - Search Results

1

The effectiveness of the combination therapy of amisulpride and quetiapine for managing treatment-resistant schizophrenia: a naturalistic study.

Quintero J, Barbudo E, Molina JD, Mur C, Ceverino A, Garcia-Resa E, Correas Lauffer J. Quintero J, et al. J Clin Psychopharmacol. 2011 Apr;31(2):240-2. doi: 10.1097/JCP.0b013e318210347c. J Clin Psychopharmacol. 2011. PMID: 21364334 No abstract available.

2

Cognitive Effects of Combined Amisulpride and Quetiapine Treatment in Patients With Refractory Schizophrenia: A Naturalistic, Prospective Study.

Molina JD, Quintero J, García-Laredo E, López-Muñoz F, Correas-Lauffer J, Barbudo E, Ceverino A, Mur C, Garcia-Resa E. Molina JD, et al. Among authors: quintero j. Am J Ther. 2020 Jul/Aug;27(4):e346-e355. doi: 10.1097/MJT.0000000000000956. Am J Ther. 2020. PMID: 31082829

3

Review of the association between obesity and ADHD.

Martínez de Velasco R, Barbudo E, Pérez-Templado J, Silveira B, Quintero J. Martínez de Velasco R, et al. Among authors: quintero j. Actas Esp Psiquiatr. 2015 Jan-Feb;43(1):16-23. Epub 2015 Jan 1. Actas Esp Psiquiatr. 2015. PMID: 25665976 Free article. Review.

4

[Nutritional aspects of attention-deficit/hyperactive disorder].

Quintero J, Rodríguez-Quirós J, Correas-Lauffer J, Pérez-Templado J. Quintero J, et al. Rev Neurol. 2009 Sep 16-30;49(6):307-12. Rev Neurol. 2009. PMID: 19728277 Free article. Review. Spanish.

5

[Update on attention-deficit/hyperactive disorder treatment].

Loro-López M, Quintero J, García-Campos N, Jiménez-Gómez B, Pando F, Varela-Casal P, Campos JA, Correas-Lauffer J. Loro-López M, et al. Among authors: quintero j. Rev Neurol. 2009 Sep 1-15;49(5):257-64. Rev Neurol. 2009. PMID: 19714557 Free article. Review. Spanish.

6

The evolving concept of Treatment- Resistant Schizophrenia.

Quintero J, Barbudo del Cura E, López-Ibor MI, López-Ibor JJ. Quintero J, et al. Actas Esp Psiquiatr. 2011 Jul-Aug;39(4):236-50. Epub 2011 Jul 1. Actas Esp Psiquiatr. 2011. PMID: 21769747 Free article. Review. English, Spanish.

7

A Phase 3, Multicenter, Open-Label, 12-Month Extension Safety and Tolerability Trial of Lisdexamfetamine Dimesylate in Adults With Binge Eating Disorder.

Gasior M, Hudson J, Quintero J, Ferreira-Cornwell MC, Radewonuk J, McElroy SL. Gasior M, et al. Among authors: quintero j. J Clin Psychopharmacol. 2017 Jun;37(3):315-322. doi: 10.1097/JCP.0000000000000702. J Clin Psychopharmacol. 2017. PMID: 28383364 Free PMC article. Clinical Trial.

8

PostCOVID Mental Health.

Quintero J, Mora F, Rodríguez-Quiroga A, Alvarez de Mon MÁ, López-Ibor MI. Quintero J, et al. Actas Esp Psiquiatr. 2020 Mar;48(2):96-8. Epub 2020 Mar 1. Actas Esp Psiquiatr. 2020. PMID: 32463917 Free article. No abstract available.

9

[Evolutionary issues in attention deficit hyperactivity disorder (ADHD); from risk factors to comorbidity and social and academic impact].

Quintero J, Loro M, Jiménez B, García Campos N. Quintero J, et al. Vertex. 2011 Mar-Apr;22(96):101-8. Vertex. 2011. PMID: 21977604 Spanish.

10

Reboxetine for ADHD in children non-responders or with poor tolerance to methylphenidate: a prospective long-term open-label study.

Quintero J, López-Muñoz F, Alamo C, Loro M, García-Campos N. Quintero J, et al. Atten Defic Hyperact Disord. 2010 Nov;2(3):107-13. doi: 10.1007/s12402-010-0027-x. Epub 2010 May 25. Atten Defic Hyperact Disord. 2010. PMID: 21432596 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

433 results

Search Page

Filters